The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Earnings-manipulation signal · Beneish M 2517.15 — flag raised, worth a closer lookWatch
- Earnings quality 52/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2024, as Traws Pharma, Inc. reports it. History and quarterly detail are in the app.
- Single Reportable$2.8M
Leadership changes
From Traws Pharma, Inc.'s own filings, the day they're filed.
- Nora Brennan · Chief Financial Officer · departureeff. 2025-07-05
- Charles Parker · Chief Financial Officer · departureeff. 2025-07-03
- Iain Dukes · Chief Executive Officer · appointmenteff. 2025-04-01
Latest filings
- 10-Q · Quarterly report2026-08-14
- 8-K · Company announcement2026-08-14
- 8-K · Company announcement2026-07-31
- 8-K · Company announcement2026-07-10
- 8-K · Company announcement2026-07-09
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Traws Pharma, Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when Traws Pharma, Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.